94 related articles for article (PubMed ID: 3602910)
21. [Clinical investigation of analgesic and anti-inflammatory effects of niflumic acid following oral surgery].
Todorović LJ; Petrović V; Kafedziska V
Stomatol Glas Srb; 1982; 29(5):325-30. PubMed ID: 6964699
[No Abstract] [Full Text] [Related]
22. [Synovial tissue levels in comparison with synovial fluid and serum concentrations following a single daily administration of 20 mg piroxicam (Felden)].
Thabe H; Fassbender HG; Laufen H; Gierend M
Z Rheumatol; 1986; 45(5):271-6. PubMed ID: 3811635
[TBL] [Abstract][Full Text] [Related]
23. High-performance liquid chromatographic determination of niflumic acid in human plasma and urine.
Avgerinos A; Malamataris S
J Chromatogr; 1990 Nov; 533():271-4. PubMed ID: 2081775
[No Abstract] [Full Text] [Related]
24. [Fluoride osteopathy induced by niflumic acid].
Hummel P; Treves R; Le Goff JJ; Vigneu P; Rousseau J
Ann Radiol (Paris); 1983 Dec; 26(8):687-90. PubMed ID: 6666981
[No Abstract] [Full Text] [Related]
25. Simultaneous determination of niflumic acid and its prodrug, talniflumate in human plasma by high performance liquid chromatography.
Jang DJ; Park JS; Ko HR; Jee JP; Kim JK; Kim ST; Kim CK
Biomed Chromatogr; 2005 Jan; 19(1):32-5. PubMed ID: 15470687
[TBL] [Abstract][Full Text] [Related]
26. Liquid chromatography-mass spectrometric method for the sensitive determination of niflumic acid in human plasma and its application to pharmacokinetic study of talniflumate tablet.
Park EJ; Na DH; Shin YH; Lee KC
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Dec; 876(2):159-62. PubMed ID: 19010744
[TBL] [Abstract][Full Text] [Related]
27. Effect of food on systemic exposure to niflumic acid following postprandial administration of talniflumate.
Kang W; Kim K; Kim EY; Kwon KI; Bang JS; Yoon YR
Eur J Clin Pharmacol; 2008 Oct; 64(10):1027-30. PubMed ID: 18607579
[TBL] [Abstract][Full Text] [Related]
28. Intracellular binding of the anti-inflammatory drug niflumic acid in the liver.
Kelmer-Bracht AM; Ishii-Iwamoto EL; Bracht A
Res Commun Mol Pathol Pharmacol; 1995 Sep; 89(3):411-9. PubMed ID: 8680809
[TBL] [Abstract][Full Text] [Related]
29. In vitro inhibitory effects of non-steroidal anti-inflammatory drugs on 4-methylumbelliferone glucuronidation in recombinant human UDP-glucuronosyltransferase 1A9--potent inhibition by niflumic acid.
Mano Y; Usui T; Kamimura H
Biopharm Drug Dispos; 2006 Jan; 27(1):1-6. PubMed ID: 16278927
[TBL] [Abstract][Full Text] [Related]
30. Opioid requirement after arthroscopy is associated with decreasing glucose levels and increasing PGE2 levels in the synovial membrane.
Högberg E; Stålman A; Wredmark T; Tsai JA; Arner P; Felländer-Tsai L
Acta Orthop; 2006 Aug; 77(4):657-61. PubMed ID: 16929445
[TBL] [Abstract][Full Text] [Related]
31. Short-term tolerability of morniflumate in patients with cutaneous hypersensitivity reactions to non-steroidal anti-inflammatory drugs.
Mero F; Nettis E; Aloia AM; Di Leo E; Ferrannini A; Vacca A
Int J Immunopathol Pharmacol; 2013; 26(1):247-50. PubMed ID: 23527729
[TBL] [Abstract][Full Text] [Related]
32. [Dysmenorrhea in puberty and adolescence].
Sirakov M; Damianov L; Tsankova M; Draganova D
Akush Ginekol (Sofiia); 2000; 39 Suppl 1():9-10. PubMed ID: 10948634
[No Abstract] [Full Text] [Related]
33. Receptor subtype-dependent positive and negative modulation of GABA(A) receptor function by niflumic acid, a nonsteroidal anti-inflammatory drug.
Sinkkonen ST; Mansikkamäki S; Möykkynen T; Lüddens H; Uusi-Oukari M; Korpi ER
Mol Pharmacol; 2003 Sep; 64(3):753-63. PubMed ID: 12920213
[TBL] [Abstract][Full Text] [Related]
34. Direct block of the cystic fibrosis transmembrane conductance regulator Cl(-) channel by niflumic acid.
Scott-Ward TS; Li H; Schmidt A; Cai Z; Sheppard DN
Mol Membr Biol; 2004; 21(1):27-38. PubMed ID: 14668136
[TBL] [Abstract][Full Text] [Related]
35. [Fluoride osteosis after 11 years of uninterrupted treatment with niflumic acid].
Bregeon C; Bernat M; Renier JC; Rebel A; Basile M
Nouv Presse Med; 1980 May; 9(20):1446-7. PubMed ID: 7383866
[No Abstract] [Full Text] [Related]
36. Application of microdialysis for the determination of muscle and subcutaneous tissue concentrations after oral and topical ibuprofen administration.
Tegeder I; Muth-Selbach U; Lötsch J; Rüsing G; Oelkers R; Brune K; Meller S; Kelm GR; Sörgel F; Geisslinger G
Clin Pharmacol Ther; 1999 Apr; 65(4):357-68. PubMed ID: 10223771
[TBL] [Abstract][Full Text] [Related]
37. [Experiences with niflumic acid in inflammatory glomerulopathies].
Boeckle H; Oechslen D; Lüttgen F; Lindenmaier K
Arzneimittelforschung; 1975 Jan; 25(1):120-2. PubMed ID: 1173764
[TBL] [Abstract][Full Text] [Related]
38. [Clinical study of the beta-morpholinoethylester of niflumic acid in children's dentistry].
Benoit P; Michelet FX; Benoit JP
Rev Odontostomatol Midi Fr; 1975; (4):249-61. PubMed ID: 1236592
[No Abstract] [Full Text] [Related]
39. Quantitative determination of niflumic acid and its beta-morpholinoethyl ester in human plasma by gas-liquid chromatography.
Houin G; Bree F; Tillement JP
J Chromatogr; 1981 May; 223(2):351-6. PubMed ID: 7251789
[TBL] [Abstract][Full Text] [Related]
40. [Fluorine osteosis caused by a very long-term niflumic acid treatment in 2 cases of rheumatoid arthritis].
Prost A; Boiteau HL; Gaillard F; Hamelin JP; Carlier N; Rossel-Renac F
Rev Rhum Mal Osteoartic; 1978 Dec; 45(12):707-16. PubMed ID: 107572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
